ID

34603

Description

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management; ODM derived from: https://clinicaltrials.gov/show/NCT01766752

Link

https://clinicaltrials.gov/show/NCT01766752

Keywords

  1. 1/19/19 1/19/19 -
  2. 4/17/20 4/17/20 -
  3. 4/17/20 4/17/20 - Sarah Riepenhausen
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes NCT01766752

Eligibility Type 2 Diabetes NCT01766752

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained after being advised of the nature of the study
Description

ID.1

Data type

boolean

male or female aged 18 - 90 years (both inclusive)
Description

ID.2

Data type

boolean

type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
Description

ID.3

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired renal function (serum creatinine ≥3.0mg/dl)
Description

ID.4

Data type

boolean

any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
Description

ID.5

Data type

boolean

pregnancy
Description

ID.6

Data type

boolean

any mental condition rendering the patient incapable of giving his consent
Description

ID.7

Data type

boolean

terminally ill patients
Description

ID.8

Data type

boolean

participation in a trial within 3 months prior to this trial
Description

ID.9

Data type

boolean

known or suspected allergy to insulin
Description

ID.10

Data type

boolean

Similar models

Eligibility Type 2 Diabetes NCT01766752

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
informed consent obtained after being advised of the nature of the study
boolean
ID.2
Item
male or female aged 18 - 90 years (both inclusive)
boolean
ID.3
Item
type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
impaired renal function (serum creatinine ≥3.0mg/dl)
boolean
ID.5
Item
any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
boolean
ID.6
Item
pregnancy
boolean
ID.7
Item
any mental condition rendering the patient incapable of giving his consent
boolean
ID.8
Item
terminally ill patients
boolean
ID.9
Item
participation in a trial within 3 months prior to this trial
boolean
ID.10
Item
known or suspected allergy to insulin
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial